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Abstract 
The effect of two different lupine protein hydrolysates (LPHs) on in vitro macrophage 
activation in a THP-1-derived macrophage model was investigated. THP-1-derived 
macrophages were exposed to RPMI medium containing two LPHs obtained by 
enzymatic hydrolysis using two different proteases: Izyme AL and Alcalase 2.4 L. 
Cytokine’s expression was measured by quantitative PCR. THP-1-derived macrophages 
exhibited attenuated expression of proinflammatory cytokines (tumour necrosis factor 
(TNF), IL-6, IL-1β) and increased expression of anti-inflammatory marker genes 
(chemokine (C-C motif) ligand 18 (CCL18)) relative to control without LPH. The anti-
inflammatory effect of both hydrolysates favoured M2 polarization by quenching C-C 
chemokine receptor type 2 (CCR2) expression and migratory capacity. Furthermore, 
LPHs significantly decreased nitric oxide production. Moreover, LPHs promoted the 
survival of human THP-1-derived macrophages. Therefore, inclusion of LPHs in foods 
may help to prevent chronic diseases associated with chronic inflammation. 
Keywords
Anti-inflammatory activity, bioactive peptides, lupine protein hydrolysates, macrophage 
polarization
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3 
1. Introduction 
The consumption of dietary protein drives many fundamental metabolic processes and is 
particularly important in nutrient-based biological functions (Gersh, Sliwa, Mayosi & 
Yusuf, 2010). In addition to providing essential amino acids to various systemic 
modulatory pathways, proteins and peptides produced by the hydrolysis of food proteins 
may also elicit potent anticancer, antimicrobial, hypocholesterolaemic, antihypertensive, 
antithrombotic, and anti-inflammatory effects (Möller, Scholz-Ahrens, Roos & 
Schrezenmeir, 2008). Bioactive peptides can be cleaved from polypeptide chains through 
gastrointestinal digestion, by fermentation or ripening during food processing, and by 
controlled hydrolytic processes using exogenous proteases (Pedroche et al., 2007). Many 
of these biologically active peptides are derived from both plant and animal sources, with 
most potentially stemming from milk-based products and legumes, such as soybean. 
Many reports have shown the potential health benefits of enzymatic hydrolysates 
prepared from milk, egg, and soy proteins (Möller et al., 2008; Shahidi & Zhong, 2008). 
Much research has focused on hydrolysates with angiotensin-converting enzyme 
inhibitory and antioxidant activities whereas other bioactive properties such as anti-
inflammatory effect are less studied. In fact, very few studies report anti-inflammatory 
properties of protein hydrolysates (Vo, Ryu & Kim, 2008; Xu, Yang, Yin, Liu & Mine, 
2012). Regarding the bioactive properties of lupine, it was previously reported that 
protein extracts from white lupine can lower plasma cholesterol (Weiβe et al., 2010) and 
triacylglycerol concentrations (Spielmann et al., 2007) in hypercholesterolaemic animal 
models. Furthermore, lupine has shown anti-atherogenic effects in laboratory animals due 
to its lipid-lowering properties. In this study, Marchesi et al. (2008) demonstrated that a 
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protein isolate from lupine reduces focal plaque development in the common carotid 
arteries in a rabbit model of atherosclerosis. However, no information has been reported 
about the anti-inflammatory properties of lupine proteins and peptides. 
Inflammation is an important normal immune response during lesions and infections. 
However, an excessive inflammation can contribute to several acute and chronic diseases 
characterised by uncontrolled production of pro-inflammatory cytokines, eicosanoids 
derived from arachidonic acid, reactive oxygen  species (ROS) and adhesion molecules 
(Calder, 2006). Therefore, inhibitors of the pro-inflammatory cytokines have been 
considered as a candidate of anti-inflammatory drugs. Chronic inflammation is a 
hallmark of several pathologies, such as rheumatoid arthritis, inflammatory bowel 
disease, atherosclerosis and cancer. The macrophage is the key player of the chronic 
inflammatory response, which the monocytic cell line THP-1 represents an appropriate 
model system to study immune responses (Weldon, Mullen, Loscher, Hurley, & Roche, 
2007). It is well known that macrophages are key players during inflammatory responses 
and their phenotype determines the cytokine secretion profile. Thus, classically activated 
M1 macrophages contribute to the development and enhancement of inflammatory and 
immunity processes and are, therefore, associated with high microbicidal activity, 
supporting the activity of Th1 cells (Mills, Kincaid, Alt, Heilman, & Hill, 2000). This 
type of activation is associated with an elevated production of pro-inflammatory 
cytokines, such as tumour necrosis factor (TNF), IL-6, and IL-1; ROS; and nitrogen 
intermediates (Cathcart, 2004). Alternative macrophage activation (M2) is triggered in 
response to IL-4 or IL-13 and is associated with tissue remodeling and immunoregulation 
(Gordon & Martinez, 2010). M2 macrophages produce anti-inflammatory cytokines, such 
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as IL-10, chemokine (C-C motif) ligand 18 (CCL18), and IL-1 receptor antagonist. Due 
to their anti-inflammatory profile, M2 macrophages are frequently associated with all 
types of activation triggered by anti-inflammatory stimuli. 
The increase in the incidence of inflammation related disorders has led to the search of 
proteins and peptides with anti-inflammatory properties (Ndiaye, Vuong, Duarte, Aluko, 
& Matar, 2012). There is evidence of the ability of distinct food compounds, including 
proteins, to modulate inflammation in experimental models involving macrophages 
(Boesch-Saadatmandi et al., 2011; Hämäläinen et al., 2011; Yu, Correll, & Vanden 
Heuvel, 2002). Indeed some peptides with anti-inflammatory activity have been purified 
from plants (Dia, Wang, Oh, de Lumen, & Gonzalez de Mejia, 2009).  
In a previous paper, we have described that blue lupine protein hydrolysates (LPHs) 
inhibited some enzymes involved in the inflammatory pathway, such as phospholipase 
A2 and cyclooxygenase-2 (Millán-Linares, Yust, Alcaide-Hidalgo, Millán, & Pedroche, 
2014). In this work, we investigated the potential anti-inflammatory activity of two lupine 
protein hydrolysates (LPHs) in a THP-1-derived macrophage model. LPHs were obtained 
by hydrolysis of lupine protein isolate (LPI) with Izyme AL and Alcalase 2.4 L, two 
food-grade proteases produced by Novozymes. Izyme AL has trypsin-like activity 
whereas Alcalase is a non-specific endoprotease. Both trypsin and Alcalase have
previously been used for the generation of bioactive peptides (Korhonen & Pihlanto, 
2006).
2. Materials and methods 
2.1 Materials 
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LPI was prepared according to Yust, Pedroche, Millán-Linares, Alcaide-Hidalgo and 
Millán (2010). Izyme AL and Alcalase 2.4 L were provided by Novozymes (Bagsvaerd, 
Denmark). The cell type used was THP-1 monocytes, ATCC® Number TIB-202TM. The 
medium for this line was Gibco® RPMI 1640 (Life Technologies SA, Alcobendas, 
Spain). PBS, foetal bovine serum (FBS), and penicillin/streptomycin (P/S) solution were 
obtained from Gibco® as well. Dimethyl sulphoxide (DMSO), formyl-methionyl-leucyl-
phenylalanine (fMLP), phorbol 12-myristate 13-acetate (PMA), trypan blue solution, and 
3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), and Griess 
reagent (1% sulphanilamide in 5% phosphoric acid and 0.1% N-naphthylenediamine-
HCl) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Ribonuclease A 
was obtained from Nacalai Tesque (Kyoto, Japan). The iScript cDNA Synthesis Kit was 
from Bio-Rad Laboratories (Hercules, CA, USA). The Annexin V-FITC Kit was obtained 
from Miltenyi Biotec GmbH (Bergisch Gladbach, Germany). Brilliant II Syber® Green 
QPCR Master Mix was purchased from Agilent Technologies (Santa Clara, CA, USA). 
Primers were purchased from Eurofins Biolab S.L.U. (Barcelona, Spain). NucleoSpin 
RNA II was obtained from Macherey-Nagel GmbH & Co. KG (Düren, Germany). 
Human TNF and IL-10 ELISA Sets were from Bionova Científica (Madrid, Spain). 
2.2 Preparation of LPHs 
Hydrolysis was performed in a bioreactor while stirring at a controlled pH and 
temperature. LPI was suspended in distilled water (10% w/v), and two types of 
hydrolysis were performed: one with Izyme AL followed by Alcalase and one using only 
Alcalase. The following conditions were used: 
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Hydrolysis with Izyme AL and Alcalase: First, LPI was hydrolysed with Izyme AL for 1 
h at pH 10, 50ºC, E/S = 100 EU/g protein. A second step of hydrolysis with Alcalase at 
pH 8, 50ºC, E/S = 0.3 AU/g protein, was then performed for 15 min. 
Hydrolysis with Alcalase: pH 8, 50ºC, E/S = 0.3 AU/g protein, and duration of hydrolysis 
of 15 min. 
Enzymes were inactivated by heating at 85ºC for 15 min, centrifuged at 8000 rpm for 15 
min, and the supernatants constituted LPHs. LPH obtained with Izyme AL followed by 
Alcalase was designated I+15A, and LPH obtained using only Alcalase was designated 
15A. 
2.3 Cell culture and treatments 
The human monocytic THP-1 cell line, was cultured in suspension in RPMI 1640 
medium supplemented with 1% P/S and 10% heat-inactivated FBS. To induce monocyte-
macrophage differentiation; THP-1 cells were cultured in the presence of PMA (100 
nmol/L) for 4 days (Weldon et al., 2007). PMA-stimulated THP-1 cells (referred to as 
THP-1-derived macrophages) were exposed to RPMI medium (supplemented with 1% 
FBS) for 24 h and then treated with the LPH I+15A or the LPH 15A at a concentration of 
500 μg/mL RPMI medium (1% FBS) for 6 h. 
2.4 Measurement of cell proliferation by the MTT method 
THP-1-derived macrophage proliferation was evaluated by measuring optical density at 
different concentrations of treatments in a 96-well plate. Cells were incubated at 37ºC 
with the LPH I+15A or the LPH 15A at final concentrations of 100, 300, 500, 700, or 
2000 µg/mL for 18 h. An aliquot of 20 μL of MTT (5 mg/mL) was added to each well 
and incubated at 37°C for 6 h. MTT is reduced to purple formazan in living cells
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(Carmicheal, DeGraff, Gazdar, Minna, & Mitchell, 1987). The supernatant was removed, 
and 200 µL of DMSO were added to each well to dissolve the insoluble purple formazan
product into a colored solution, followed by shaking for 10 min. Absorbance was 
measured at 570 nm using a microplate reader, and cell proliferation was calculated. 
RPMI medium (1% FBS) was used as control. 
2.5 Analysis of cellular DNA content 
Cellular DNA content was assessed by propidium iodide (PI) staining and FACS analysis 
as previously described, with modifications (Mills et al., 2000). The cells were exposed to 
RPMI medium (1% FBS) containing the LPH I+15A or the LPH 15A at a concentration 
of 500 μg/mL for 24 h of treatment. The cells were then fixed in 1% paraformaldehyde in 
PBS containing 0.5% saponin for 5 min at 4ºC. After centrifugation, the cells were 
incubated in buffer containing 5 μg/mL PI and 1 mg/mL ribonuclease A for 10 min at 
4ºC. The cells were analyzed using a BD FACSCanto II flow cytometer and BD 
FACSCanto II Software (BD Biosciences, San Jose, CA, USA). FBS 1% and FBS 10% 
were used as negative and positive control, respectively. Cells that were hypodiploid due 
to DNA fragmentation were regarded as apoptotic cells. 
2.6 Cell viability 
Cells were exposed to the LPH I+15A or the LPH 15A at 100, 300, 500, 700, 1000, or 
2000 µg/mL for 24 h, rinsed with PBS, and evaluated for live/dead cells using the trypan 
blue exclusion test. Viable cells excluded the dye, whereas dead cells were stained an 
intense blue. At least 200 cells were scored to assess live/dead cells. The number of 
viable cells was quantified by confocal microscopy (Olympus IX81, Tokyo, Japan). 
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RPMI medium (1% FBS) was used as control. Cells were tested in triplicate, and the 
results were averaged. 
2.7 Measurement of apoptotic cells 
Early events associated with apoptosis were evaluated using the binding of annexin V to 
detect the translocation of phosphatidylserine from the inner side to the outer leaflet of 
the plasma membrane of apoptotic cells and using PI to detect the DNA of necrotic cells, 
as described in the Annexin V-FITC Kit. An analysis of stained cells was performed by 
measuring fluorescence emission using a BD FACSCanto II flow cytometer at 530 nm 
and 585 nm for fluorescein isothiocyanate and PI, respectively, and using BD 
FACSCanto II Software. RPMI medium (1% FBS) was used as control and staurosporine 
(pro-apoptotic) as positive control. 
2.8 mRNA extraction and analysis of PCR products 
Total RNA was extracted from the THP-1-derived macrophages using NucleoSpin® RNA 
II. RNA quality was assessed using the OD260:OD280 ratio determined by a NanoDrop 
ND-1000 Spectrophotometer (Thermo Scientific, Waltham, MA, USA). One microgram 
of total RNA was subjected to RT-PCR to obtain cDNA according to the manufacturer’s 
protocol. 
The mRNA levels for specific genes were determined using an Mx3000P Real-Time PCR 
System (Stratagene, La Jolla, CA, USA). For each QPCR, 10 ng of cDNA template was 
added to Brilliant SYBR Green QPCR Master Mix containing primer pairs for TNF, IL-
6, IL-1β, CCL18, C-C chemokine receptor type 2 (CCR2), and chemokine (C-C motif) 
ligand 2 (CCL2). The reference genes HPRT and GAPDH were used to correct for RNA 
concentration differences between the samples. 
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The sequence of and information about the primers that were used in this study are as 
follows: TNF (NM_000594.3): 5′-TCCTTCAGACACCCTCAACC-3′ and 5′-
AGGCCCCAGTTTGAATTCTT-3′ (reverse); IL-6 (NM_001001928): 5′-
GTTTGAGGGGGTAACAGCAA-3′ and 5′-GCTAACTGCAGAGGGTGAGG-3′; IL-1β
(NM_138712): 5′-GCTGTGCAGGAGATCACAGA-3′ and 5′-
GGGCTCCATAAAGTCACCAA-3′; CCL18 (NM_002957): 5′-
GGGTTTTCTTCCCTTTCGAG-3′ and 5′-GCGTGTTCCTTTTCCACAAT-3′; CCR2 
(NM_001002): 5′-TCGACAATGGCAGCATCTAC-3′ and 5′-
ATCCGTCTCCACAGACAAGG-3´; CCL2 (NM_002982.3): 5´-
CCCCAGTCACCTGCTGTTAT-3´ and 5´-TGGAATCCTGAACCCACTTC-3´; HPRT 
(NM_000194.2): 5´-ACCCCACGAAGTGTTGGATA-3´ and 5´-
AAGCAGATGGCCACAGAACT-3´; and GAPDH (NM_002046.4): 5′-
GAGTCAACGGATTTGGTCGT-3′ and 5′-TTGATTTTGGAGGGATCTCG-3′.
All amplification reactions were performed in triplicate. The magnitude of the change in 
mRNA expression for the candidate genes was calculated using the standard 2–(ΔΔCt)
method. All data were normalized to endogenous reference genes (HPRT and GAPDH) 
levels and expressed as a percentage of the control. 
2.9 Enzyme-linked immunosorbent assay (ELISA). 
TNF and IL10 concentrations in cell culture supernatants were quantified by commercial 
ELISA kits according to manufacturer’s instructions. 
2.10 Measurements of nitrite in THP-1-derived macrophages cells.  
As an indicator of NO production, nitrite (NO2-) concentration was measured in the cell 
culture supernatants. Equal volumes of culture supernatants and Griess reagent were 
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mixed and the absorbance was read at 540 nm in the microplate reader (Green et al.,
1981). The amount of nitrite was obtained by an extrapolation from a standard curve with 
sodium nitrite. 
2.11 Migration assays 
THP-1-derived macrophages were collected in RPMI-1640 medium containing 10% 
FBS, and 1% P/S and seeded in 24-well culture plates at 5 × 105 per well to allow high-
density adhesion of the macrophages. After removing the floating cells, the adherent cells 
were incubated at 37°C in 5% CO2 for 24 h to form a confluent monolayer. The 
macrophage monolayer was wounded by scratching with a thin pipette tip. The cells were 
treated with each LPH (I+15A and 15A) and allowed to migrate for 24 h. The migration 
of THP-1-derived macrophages was examined and quantified by confocal microscopy. 
Images were captured at the beginning and at 24 h of cell migration to close the wound 
and compared to quantify the migration rates of the cells. 
2.12 Statistical analysis 
The data are presented as the mean ± SEM of three independent determinations. Group-
wise statistical comparisons were performed by a one-way ANOVA with a post-hoc 
Bonferroni test. Differences were considered to be significant at P < 0.05. 
3. Results and discussion 
3.1 LPHs does not alter the cellular integrity of THP-1-derived macrophages 
Before assessing the anti-inflammatory activity, cell viability and the potential 
cytotoxicity of the LPHs were evaluated (Gülden & Seibert, 2003). 
To investigate whether LPHs may cause a cytotoxic effect, an MTT assay was performed 
on THP-1-derived macrophages after separately adding each LPHs at increasing 
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concentrations to conditioned RPMI culture medium for 6 h. The LPHs I+15A and 15A 
had no significant effects (Fig. 1A and 1B) compared with the untreated control group. 
Moreover, using flow cytometric analysis to study the DNA distribution in the cell cycle
(Sawai & Domae, 2008), we observed that the percentage of S population among THP-1-
derived macrophages treated with the LPH I+15A or the LPH 15A was slightly increased 
(Fig. 1C), but did not reach significance. For the quiescent phase (G0/G1) and G2/M 
population no differences were found in relation to the control (1% FBS). For all 
samples, even though a degree of proliferative activity, which was not significant, was 
observed, the cells remained in the quiescent phase for a longer period. The addition of 
10% FBS was used as a positive control. 
The contribution of LPHs to the activation of programmed cell death (apoptosis) was also 
investigated. Interestingly, apoptosis was reduced in the presence of the LPH 60I+15A or 
the LPH 15A (29 and 35%, respectively) compared with the control (Fig. 1D). This effect 
seems to endow both LPHs with a protective effect against apoptosis. To complete the 
feasibility studies of the LPHs, cell viability was assayed by trypan blue exclusion in 
THP-1-derived macrophages treated with increasing concentrations of the LPH I+15A or 
the LPH 15A for 24 h. As expected, there was no differences in cell viability after 24 h of 
incubation in the presence of higher concentrations of the LPH I+15A, which ranged 
from 100 to 2000 µg/mL, when compared with the control (Fig. 2A). The same pattern 
was observed after treatment with the LPH 15A (Fig. 2B). 
Taken together, these results suggest that in general, LPHs do not compromise the 
integrity of THP-1-derived macrophages. Although cell viability was decreased upon 
exposure to higher concentrations, this decrease did not reach 30% cell loss for either of 
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the LPHs tested. Hence, LPHs did not have any major effect on membrane integrity in 
the selected cell model. 
3.2 Effect of LPHs on the expression of pro and anti-inflammatory cytokines 
Several diseases, such as obesity-associated insulin resistance, diabetes, and metabolic 
syndrome, are sustained by chronic subclinical inflammation (Faloia et al., 2012). 
Elevated levels of cytokines, such as leptin, TNF, IL-1, and IL-6, are generally increased 
during inflammatory diseases (Hajer, Van Haeften, & Visseren, 2008). A growing body 
of evidence has shown that biologically active peptides derived from plants can prevent 
many inflammatory disorders due to the peptides’ antioxidant and anti-inflammatory 
effects (Politis, Theodorou, Lampidonis, Chronopoulou, & Baldi, 2012; Vernaza, Día, & 
González de Mejía, 2012). Classically activated macrophages (with an M1 phenotype) 
mediate tissue damage and initiate inflammatory responses by releasing pro-
inflammatory mediators (Olefsky & Glass, 2010). These mediators recruit additional 
macrophages, establishing a feed-forward process that further increases leukocytes 
content and propagates the chronic inflammatory state (Shen, Lu, Duan, & Duan, 2011). 
Herein, we first evaluated the ability of LPHs (I+15A and 15A) to modulate the 
expression of the pro-inflammatory cytokines TNF, IL-1β, and IL-6 in THP-1-derived 
macrophages (Fig. 3A-C). TNF showed significant inhibition after 6 h of incubation with 
either hydrolysate. This reduction was markedly pronounced after I+15A treatment 
(TNF: -45%, IL-1: -32%, and IL-6: -43%). The LPH 15A induced the downregulation of 
TNF and IL-1 in activated macrophages by 30 and 35%, respectively, whereas IL-6 
levels were blunted (70%). No significant differences were observed between the 
treatments. These results indicate that LPHs tend to decrease the pro-inflammatory 
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capacity of activated M1 macrophages by diminishing cytokines expression, setting a 
trend of regulation of the inflammatory process. Macrophage polarization dramatically 
alters the immune properties of these cells, as evidenced by the potent anti-microbial 
properties of M1 macrophages compared with the prominent anti-inflammatory tissue 
repair properties of M2 macrophages (Joshi et al., 2010). Depending on the cytokine 
microenvironment, the M2 macrophage phenotype is characterized by the expression of 
cell surface proteins such as CD206 and CD163 and of soluble factors such as CCL18 
(Bellón et al., 2011). To corroborate the hypothesis that LPHs have potential anti-
inflammatory role, the expression of CCL18 and IL10 (an M2 markers) after 6 h of 
incubation with the LPHs 15A or the LPH I+15A were evaluated. Surprisingly, both 
LPHs highly increased CCL18 expression, doubling the value compared with the control 
(Fig. 3D). However, no significant differences were observed in the IL10 expression In 
THP-1-derived macrophages after treatment with LPHs (Fig. 3E). 
Taken together, these data suggest that the LPHs I+15A and 15A may have a beneficial 
capability to skew activated M1 macrophages toward the anti-inflammatory M2 
phenotype.  
3.3 Effect of LPHs on cytokines production  
To corroborate the effect of LPHs on cytokines mRNA expression, the concentration of 
TNF and IL-10 was measured in cell culture supernatants. The production of TNF was 
decreased by both LPHs (Fig. 4A). This inhibition was higher in LPH I+15A, which 
inhibited more than 80% TNF production. Regarding IL-10, significant differences were 
not observed among LPHs and control (Fig. 4B). These data coincided with the ones
obtained by quantitative PCR, where THP-1-derived macrophages exhibited attenuated 
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expression of proinflammatory cytokine TNF, and showed no significant differences in 
the expression of IL-10. 
3.4 Effect of LPHs on the nitrite production 
Nitric oxide (NO) has been shown to play a central role in inflammatory and immune 
reaction activities and macrophages appear to be the main cellular source of NO 
(Montserrat-de la Paz, Fernández-Arche, Ángel-Martín & García-Giménez, 2012). The 
effect of LPHs on the release of this inflammatory mediator is depicted in Fig. 5. Both 
LPHs inhibited approximately 50% of NO production. Other legume protein hydrolysates 
have shown inhibition of NO production by activated macrophages (Ndiaye et al., 2012). 
3.5 LPHs impair the chemotactic capacity of human THP-1-derived macrophages 
Previously, Fontanari, Batistuti, da Cruz, Hilario, and Saldiva (2012) investigated the 
potential hypolipidaemic effect of a total protein extract from Lupinus albus, which is 
associated with a mechanism shared with soya proteins (Duranti et al., 2004; Lovati et al., 
2000; Lovati, Manzoni, Gianazza & Sirtori, 1998). Furthermore, soy-based diets have 
been shown to reduce atherosclerotic lesions through downregulation of the expression 
levels of monocyte chemokines essential for the initiating events in atherosclerosis, such 
as monocyte chemoattractant protein-1 (MCP-1) or CCL2. CCL2 have a systemic role in 
the regulation of metabolism, and particularly in controlling leukocyte extravasation and 
chemotaxis toward inflamed tissues. For instance, Weisberg et al. (2006) reported a 
significant reduction in plaque macrophage content in mice lacking CCR2 (CCR2-/-
mice). Furthermore, certain evidence has indicated an increase in M1 and decrease in M2 
macrophages in obese adipose tissue (Lumeng, Bodzin, & Saltiel, 2007). Interestingly, 
such a phenotypic switch was not observed in CCR2-/- mice, suggesting that the MCP-
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1/CCR2 pathway could contribute to M2 macrophage polarization.  
We hypothesized that as occurs with soy proteins, lupine hydrolysates may exert a 
beneficial effect on the chemotaxis mechanism by modulating the CCR2/CCL2 axis. To 
examine this issue, the expression of CCR2 and CCL2 in human THP-1-derived 
macrophages was evaluated after 6 h of incubation with either LPH. As expected, the 
CCL2/CCR2 axis was noticeably modulated by both LPHs. Fig. 4A shows a dramatic 
reduction in CCR2 expression by the LPH I+15A (-62%), whereas this expression was 
more blunted by the LPH 15A (-84%). Despite the significant reduction in CCR2, we 
could not find any significant difference in the expression of its ligand, CCL2 (Fig. 4B), 
but did note a decreasing tendency. Accordingly, the migration index was reduced after 
24 h of treatment with the LPH I+15A (-44%) or the LPH 15A (-58%). A potent 
chemotactic agent, fMLP, was used as positive control (Fig. 4C).  
Thus far, the results indicate that the addition of LPHs to fully differentiated THP-1 
macrophages results in the decreased expression of both CCR2 and CCL2 and, 
consequently, a decrease in the cells’ migration capability. These findings suggest that 
infiltrating activated macrophages exposed to LPHs may lose their chemotactic ability, 
which ameliorates the inflammatory state. 
In conclusion, after LPH treatment, THP-1-derived-macrophages showed attenuated 
expression of TNF, IL-6, IL-1β (proinflammatoty cytokines) and increased expression of 
CCL18 (antiinflammatory). Moreover, NO production was inhibited. Thereby, LPHs 
displayed hyporeactivity to M1-type ligands and polarization to the M2 phenotype. 
Furthermore, our data demonstrates that both LPHs attenuate the macrophage migratory 
response, which is partly mediated by skewing THP-1-derived macrophages toward 
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alternatively activated M2 macrophages, which are equipped for repair and resolution of 
the inflammatory response. Thus, this study is the first to describe the anti-inflammatory 
effect of LPHs in THP-1-derived macrophages and the influence in the control of 
macrophage polarization in the context of inflammatory state. 
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FIGURE CAPTIONS 
Figure 1. Effect of LPHs (500–2000 μg/mL) I+15A (A) and 15A (B) on cell proliferation 
of human THP-1-derived macrophages determined by MTT assay after 6 h. Study of the 
DNA distribution in the cell cycle ( % G0/ G1, % S and % G2/M) in THP-1- derived 
macrophages treated with LPH I+15A or LPH 15A (C). Percentage of apoptotic cell 
death in THP-1-derived macrophages after exposure to LPHs at 500 µg/mL for 24 h (D). 
Values marked with different letter are significantly different (P < 0.05).
Figure 2. Cell viability (%), determined by trypan blue exclusion assay, in presence of 
LPHs I+15A (A) and 15A (B), after 24 h of treatment and different concentrations (100-
2000 µg/mL). Some images obtained with confocal microscopy are presented.
Figure 3. TNF (A), IL-1β (B), IL-6 (C),  CCL18 (D), and IL10 (E) mRNA expression in  
THP-1-derived macrophages after 6 h of treatment with LPHs (I+15A, and 15A). Values 
marked with different letter are significantly different (P < 0.05).
Figure 4. Effect on TNF (A) and IL-10 (B) production of THP-1-derived macrophages. 
after 48 h of treatment with LPHs (I+15A, and 15A). Values marked with different letter 
are significantly different (P < 0.05). 
Figure 5. NO production (%) in THP-1-derived macrophages after 48 h of treatment with 
LPHs (I+15A, and 15A). Values marked with different letter are significantly different (P 
< 0.05). 
Figure 6. CCR2 (A) and CCL2 (B) mRNA expression in THP-1-derived macrophages 
after 6 h of treatment with LPHs (I+15A, and 15A). Migration Index (C) of THP-1-
derived macrophage after 24 h of incubation. Values marked with different letter are 
significantly different (P < 0.05). 
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